FILING ANALYSIS · FRIDAY, NOVEMBER 13
DYADIC INTERNATIONAL INC DYAI — 8-K: Results of Operations and Financial Condition
neutral
Dyadic International reported its first direct commercial protein sales and announced progress in its partnerships and production platforms, but noted that early sales remain modest and evaluation timelines are longer than anticipated. The company also expects to receive a $225,000 milestone payment from Inzymes in the fourth quarter of 2026.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →